961 Mziaut, H
Acute kidney injury : Dehydration from gastrointestinal side effects may impair kidney function, particularly in patients with existing renal impairment
DIRECTIONS FOR FUTURE RESEARCH The clinical use of GLP-1RAs and dual GIP/GLP-1RAs has risen sharply in recent years, driven by their proven efficacy in managing T2DM and obesity
Interventions aimed at preserving muscle mass and function such as resistance exercise, sufficient protein intake, optimized nutrition, and appropriate pharmacological agents are essential
In both studies, participants read descriptions about a fictional 38-year-old individual who had experienced obesity since puberty
When we talk about boosting or activating GLP-1, we mean increasing the levels of this hormone to enhance its effects on metabolism, insulin regulation, and appetite suppression. This is what GLP-1 medications do